Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

Kurma Partners. (4/13/21). "Press Release: Jean-François Rivassou Joins Kurma Partners as Partner". Paris.

Organisations Organisation Kurma Partners (Kurma Life Sciences Partners)
  Group Kurma (Group)
  Organisation 2 ISAI Gestion
  Group ISAI (Group)
Products Product venture capital
  Product 2 LIFE SCIENCES
Persons Person Rivassou, Jean-François (Kurma Partners 202104– Partner before ISAI Gestion + Adenclassifieds + Banexi Ventures)
  Person 2 Merigeau, Nicolas (NewCap 201502)
     


Kurma Partners, a leading European venture capital company in the field of Life Sciences based in Paris and Munich with nearly 500 million euros under management, today announced the appointment of Jean-François Rivassou as Partner.

Jean-François Rivassou, 45, has been appointed as Partner to further support Kurma Partners life sciences portfolio companies in their late-stage development.

Jean-François was previously in charge of growth and private equity investments at ISAI Gestion, a Paris based tech fund. From 2006 to 2012, he was Head of M&A and Business Development, and a member of Adenclassifieds’ management committee, a digital company listed on Euronext Paris. Prior Adenclassifieds, he worked as an investment manager at Banexi Ventures Partners, a BNP Paribas backed VC fund, where he was responsible for biotech and medtech investments. Jean-François started his career at Genset, a Euronext and Nasdaq listed genomics company, in the group’s Singaporean subsidiary. Jean-François graduated from the Ecole Nationale Supérieure des Mines de Paris, a leading generalist engineering school, where he specialized in Biotechnology.

In a context of increasing maturity of the European Life Sciences ecosystem, the appointment of Jean-François illustrates Kurma Partners’ ambition to strengthen, in an integrated manner, its expertise in the more advanced phases of development of its portfolio companies.


About Kurma Partners : www.kurmapartners.com

Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).


NewCap

Nicolas Merigeau
Medias Relations
Phone nb.: +33 (0)1 44 71 94 98
Email: nmerigeau@newcap.fr


   
Record changed: 2021-04-27

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Kurma (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group ChinaBio Partnerting Forum 2021 651x80




» top